Penlac® Nail Lacquer
(ciclopirox) Topical Solution, 8%
PENLAC® NAIL LACQUER (ciclopirox) Topical Solution, 8%, contains a synthetic antifungal agent, ciclopirox. It is intended for topical use on fingernails and toenails and immediately adjacent skin.
PENLAC® NAIL LACQUER (ciclopirox) Topical Solution, 8%, as a component of a comprehensive management program, is indicated as topical treatment in immunocompetent patients with mild to moderate onychomycosis of fingernails and toenails without lunula involvement, due to
Trichophyton rubrum. The comprehensive management program includes removal of the unattached, infected nails as frequently as monthly, by a health care professional who has special competence in the diagnosis and treatment of nail disorders, including minor nail procedures.
Media Articles Related to Penlac (Ciclopirox Topical)
Is Testing Needed Before Treating Onychomycosis With Terbinafine?
Source: Medscape Dermatology Headlines [2016.04.19]
Does it still make sense to order confirmatory testing prior to treating onychomycosis with oral terbinafine?
Nail Fungus (Onychomycosis)
Source: MedicineNet Fungal Nails Specialty [2016.04.01]
Title: Nail Fungus (Onychomycosis)
Category: Symptoms and Signs
Created: 4/1/2016 12:00:00 AM
Last Editorial Review: 4/1/2016 12:00:00 AM
Treating Onychomycosis With Laser Light
Source: MedicineNet Fungal Nails Specialty [2016.02.24]
Title: Treating Onychomycosis With Laser Light
Category: Doctor's & Expert's views on Symptoms
Created: 6/7/2012 12:00:00 AM
Last Editorial Review: 2/24/2016 12:00:00 AM
Published Studies Related to Penlac (Ciclopirox Topical)
A randomized, double-blind study comparing the efficacy of selenium sulfide shampoo 1% and ciclopirox shampoo 1% as adjunctive treatments for tinea capitis in children. [2010.09]
Our objective was to compare the efficacy of selenium sulfide shampoo 1% and ciclopirox shampoo 1% as adjunctive treatments for tinea capitis in children. Forty children aged 1-11 years with clinically diagnosed tinea capitis were randomized to receive selenium sulfide shampoo 1% or ciclopirox shampoo 1% twice a week as adjuncts to an 8-week course of ultramicronized griseofulvin dosed at 10-12 mg/kg/day...
Randomized study comparing the efficacy and tolerance of a lipohydroxy acid shampoo to a ciclopiroxolamine shampoo in the treatment of scalp seborrheic dermatitis. [2009.12]
BACKGROUND: The success of a dandruff treatment depends not only on the ability of a shampoo to control dandruff, but also on patient compliance, which is closely linked to the cosmetic attributes of the product. AIM: The aim of this study was to compare efficacy, tolerance, and cosmetic properties of a LHA Shampoo [containing 0.1% lipohydroxy acid (LHA) and 1.3% salicylic acid] to a CPO shampoo [containing 1.5% ciclopiroxolamine (CPO), 3% salicylic acid, and 0.5% menthol] in subjects with seborrheic dermatitis (SD) of the scalp... CONCLUSION: In conclusion, these results demonstrated that the lipohydroxy acid shampoo evaluated in this study is a more convenient, efficient, safe, and well-tolerated cosmetic treatment for mild-to-moderate seborrheic dermatitis of the scalp than a ciclopiroxolamine shampoo.
Clinical efficacy of a new ciclopiroxolamine/zinc pyrithione shampoo in scalp seborrheic dermatitis treatment. [2006.09]
Ciclopiroxolamine (CPO) and Zinc Pirythione (ZP) antifungals are efficient at treating scalp seborrheic dermatitis.This multicentre, single-blind, clinical study was conducted to evaluate the efficacy of a shampoo containing the 1.5% CPO/1% ZP association compared to the vehicle shampoo and to 2% ketoconazole foaming gel in the treatment of seborrheic dermatitis.In 189 patients randomised to apply 1 of the 3 products twice a week for 28 days, the global lesional score, erythema, pruritus, global efficacy, quality of life (SF12 and DLQI questionnaires) and tolerance were measured at 0, 7, 14 and 28 days.The 3 products reduced lesional score, erythema and pruritus from day 7 (p < 0.0001)...
Treatment of head and neck dermatitis with ciclopiroxolamine cream--results of a double-blind, placebo-controlled study. 
In atopic dermatitis, microbial allergens may be pathogenetically significant...
Ciclopirox topical solution, 8% combined with oral terbinafine to treat onychomycosis: a randomized, evaluator-blinded study. [2005.07]
This randomized, evaluator-blind, 3-arm parallel, comparator controlled, multicenter pilot study evaluated the safety and efficacy of ciclopirox nail lacquer topical solution, 8% in combination with oral terbinafine for the treatment of moderate to severe toenail onychomycosis (> or =60% disease involvement of target nail and/or lunula/matrix involvement) (N = 73)...
Clinical Trials Related to Penlac (Ciclopirox Topical)
Study Evaluating the Tolerance and Biologic Activity of Oral Ciclopirox Olamine in Patients With Relapsed or Refractory Hematologic Malignancy [Completed]
This is an open-label, single arm study. Approximately 3-30 patients will be enrolled.
Patients will receive Oral ciclopirox olamine (aqueous suspension), initial starting dose of
5 mg/m2/day administered as a single dose daily for 5 days. Three patients will initially be
treated at each dose level in sequential cohorts. Dose escalation will continue for each
subsequent cohort based on toxicity and plasma drug concentrations observed during the
previous cohort. Dose escalation will continue until establishment of the maximum tolerated
dose (MTD) has been met.
Patients who have demonstrated response to treatment, up to 6 total cycles of treatment may
be administered. If additional cycles are warranted, ciclopirox olamine will be given at
the same dose and frequency as the patient initially received.
Safety and Equivalence of a Generic Ciclopirox Olamine Cream Compared to the Reference Ciclopirox Cream 0.77% for the Treatment of Tinea Pedis [Completed]
The objectives of this study were to demonstrate comparable safety and efficacy of
Ciclopirox Olamine Cream (Test Product) and Ciclopirox Cream 0. 77% (Reference Product) in
the treatment of subjects with tinea pedis, and to show the superiority of the active
treatments over that of the vehicle.
Safety Study of Ciclopirox Olamine Cream for Dermatomycoses in Children [Terminated]
Ciclopirox olamine (CiclochemŪ) is a pyridone broad spectrum antifungal drug which has
shown activity on dermatophytes, yeasts, moulds, actinomycetes and some bacteria. Its
mechanism of action is based on a fungicidal activity by inhibiting the cellular captation
of essential substances needed for the metabolism and growth of the fungi. On the other
hand, this drug binds irreversibly with cell structures as mitochondria, ribosomes,
microsomes and cell wall. After dermal application, Ciclopirox olamine undergoes skin
penetration, being only absorbed a 1,5% of the applied dose. Clinical efficacy has been
studied in patients above 10 years with superficial dermatomycoses (dermatophytoses,
candidiasis and pityriasis versicolor) and the percentage of clinical healing ranged from
77% to 91% after 2-4 weeks of twice a day topical application. In all the studies, the
safety profile has been very good, showing only a very low rate of adverse events of mild to
moderate intensity. There are very few previous available data on the application of this
compound in children under 10 years of age. A single study had been performed with a
solution formulation in patients from 6 to 29 months with diaper candidiasis, showing good
efficacy and tolerability in these patients. The present study aims to show the safety and
tolerability of ciclopirox olamine in a cream formulation in patients from 3 months to 10
years with dermatomycoses.
Efficacy, Safety and Cost-effectiveness of a Sequential Therapy With RV4104A Ointment, Ciclopiroxolamine Cream and Ciclopirox Film-forming Solution Compared With Amorolfine Nail Lacquer in Dermatophytic Onychomycosis [Recruiting]
The purpose of the study is to evaluate and compare the efficacy of the sequential
association RV4104A ointment followed by ciclopiroxolamine 1% cream and ciclopirox 8%
film-forming solution versus amorolfine 5% nail lacquer alone in the treatment of patients
with dermatophytic onychomycosis (toenail) without matrix involvement.
Topical Penlac Nail Lacquer for Onychomycosis in Children [Completed]
Five months of therapy is sufficient to treat onychomycosis in children. Topical therapy of
onychomycosis in children with Penlac nail lacquer has comparable efficacy and a superior
cost and safety profile compared to systemic therapy.
PATIENT REVIEWS / RATINGS / COMMENTS
Based on a total of 2 ratings/reviews, Penlac has an overall score of 1. The effectiveness score is 2 and the side effect score is 10. The scores are on ten point scale: 10 - best, 1 - worst.
Penlac review by 51 year old female patient
|Overall rating:|| || |
|Effectiveness:|| || Ineffective|
|Side effects:|| || No Side Effects|
|Condition / reason:|| || toe nail fungus|
|Dosage & duration:|| || topical solution-nail lacquer (dosage frequency: once a day) for the period of 3 months so far|
|Other conditions:|| || none|
|Other drugs taken:|| || Naftin|
|Benefits:|| || none-I'm still taking it until the bottle runs out (like 3 more months) but I'm not optimistic. My dermatologist said toe nail fungus is really hard to treat. I have it on my big toe and it's not pretty. I tried homemade remedies first-white vinegar, hydrogen peroxide and Vicks vapo rub (which didn't work either but I swear better than both of the medications) The I tried Naftin gel for 3 months and now the paint-on Penlac generic.|
|Side effects:|| || none-my frustration, lost money (the generic is $99/bottle)|
|Comments:|| || Paint the nail lacquer onto the infected nail, one coat a day, At the end of the week, remove it with alcohol and start the process all over again. Unfortunately, it seems like my nail isn't growing, which is why I'm afraid if I remove the nail (with a podiatrist) that it may not grow back-my dermatologist agrees I should not have the nail removed; she wants me to live with it. She says that even with Lamasil and all that expense and liver damaging drug, the fungus can still come back in 2 months.|
Penlac review by 54 year old female patient
|Overall rating:|| || |
|Effectiveness:|| || Ineffective|
|Side effects:|| || No Side Effects|
|Condition / reason:|| || Toenail fungus|
|Dosage & duration:|| || Topical twice a day (dosage frequency: twice a day) for the period of One month then repeated|
|Other conditions:|| || No other conditions|
|Other drugs taken:|| || None|
|Benefits:|| || None - did not work|
|Side effects:|| || No Side effects|
|Comments:|| || Topical application did not work. Tried other prescription drugs as well (topical) but did not work. Finally was advised to try a 1:5 solution of white vinegar and this cleared up the issue. The vinegar made the nail bed inhospitable to fungus and nails grew in perfect, solving this 20+ year problem that plagued me. I recommend anyone suffering from nail bed fungus to try this. I put the solution in plastic bags tied with elastic bands and walked around with them for an hour a day. Small price to pay for relief of this nasty affliction. |
Page last updated: 2016-04-19